Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management SYC Tong, JS Davis, E Eichenberger, TL Holland, VG Fowler Jr Clinical microbiology reviews 28 (3), 603-661, 2015 | 5186 | 2015 |
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial JM Dulhunty, JA Roberts, JS Davis, SAR Webb, R Bellomo, C Gomersall, ... Clinical infectious diseases 56 (2), 236-244, 2013 | 433 | 2013 |
Continuous versus intermittent β-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials JA Roberts, MH Abdul-Aziz, JS Davis, JM Dulhunty, MO Cotta, J Myburgh, ... American journal of respiratory and critical care medicine 194 (6), 681-691, 2016 | 416 | 2016 |
A multicenter randomized trial of continuous versus intermittent β-lactam infusion in severe sepsis JM Dulhunty, JA Roberts, JS Davis, SAR Webb, R Bellomo, C Gomersall, ... American journal of respiratory and critical care medicine 192 (11), 1298-1305, 2015 | 260 | 2015 |
Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients CJ Darcy, G Minigo, KA Piera, JS Davis, YR McNeil, Y Chen, ... Critical Care 18, 1-12, 2014 | 204 | 2014 |
Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a … SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson, J Nelson, S Archuleta, ... Jama 323 (6), 527-537, 2020 | 194 | 2020 |
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial JS Davis, A Sud, MVN O'Sullivan, JO Robinson, PE Ferguson, H Foo, ... Clinical Infectious Diseases 62 (2), 173-180, 2016 | 185 | 2016 |
Management of bone and joint infections due to Staphylococcus aureus. JS Davis Internal medicine journal 35, S79-96, 2005 | 142 | 2005 |
Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia's Northern Territory SM Flint, JS Davis, JY Su, EP Oliver‐Landry, BA Rogers, A Goldstein, ... Medical Journal of Australia 192 (10), 617-622, 2010 | 130 | 2010 |
Rhabdomyolysis associated with dengue virus infection JS Davis, P Bourke Clinical Infectious Diseases 38 (10), e109-e111, 2004 | 119 | 2004 |
Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity JS Davis, TW Yeo, KA Piera, T Woodberry, DS Celermajer, DP Stephens, ... Critical care 14, 1-8, 2010 | 118 | 2010 |
Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections JS Davis, S van Hal, SYC Tong Seminars in respiratory and critical care medicine 36 (01), 003-016, 2015 | 115 | 2015 |
The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: the results of a large multicenter study J Lora-Tamayo, É Senneville, A Ribera, L Bernard, M Dupon, V Zeller, ... Clinical infectious diseases 64 (12), 1742-1752, 2017 | 112 | 2017 |
An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function CJ Darcy, JS Davis, T Woodberry, YR McNeil, DP Stephens, TW Yeo, ... PloS one 6 (6), e21185, 2011 | 110 | 2011 |
A novel clinical grading scale to guide the management of crusted scabies JS Davis, S McGloughlin, SYC Tong, SF Walton, BJ Currie PLoS neglected tropical diseases 7 (9), e2387, 2013 | 108 | 2013 |
Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia S Weis, M Kesselmeier, JS Davis, AM Morris, S Lee, A Scherag, S Hagel, ... Clinical Microbiology and Infection 25 (7), 818-827, 2019 | 103 | 2019 |
Infectious complications of biological and small molecule targeted immunomodulatory therapies JS Davis, D Ferreira, E Paige, C Gedye, M Boyle Clinical microbiology reviews 33 (3), 10.1128/cmr. 00035-19, 2020 | 102 | 2020 |
Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond NE Holmes, SYC Tong, JS Davis, SJ Van Hal Seminars in respiratory and critical care medicine 36 (01), 017-030, 2015 | 100 | 2015 |
Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort … AA Udy, JM Dulhunty, JA Roberts, JS Davis, SAR Webb, R Bellomo, ... International journal of antimicrobial agents 49 (5), 624-630, 2017 | 98 | 2017 |
Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration I Bilgrami, JA Roberts, SC Wallis, J Thomas, J Davis, S Fowler, ... Antimicrobial agents and chemotherapy 54 (7), 2974-2978, 2010 | 96 | 2010 |